Beverly Green, MD, MPH, is a physician scientist known for pioneering work in preventive and evidence-based medicine. With a goal of improving systems of care, she designs and evaluates programs that make effective treatment easier for patients to follow through with — and easier for providers to deliver.
Dr. Green’s research has a strong public health emphasis, targeting conditions that impact large proportions of the population — such as cardiovascular disease, cancer, and obesity — with an emphasis on leveraging technologies and systems-based care.
In 2022, Dr. Green published the results of the BP-CHECK study, which compared the accuracy and acceptability of ways to diagnose high blood pressure. With a $2.8 million award from PCORI (the Patient-Centered Outcomes Research Institute), the study compared blood pressures taken in clinic, at home, and at validated blood pressure kiosks to the 24-hour blood pressure test that is currently considered the gold standard for diagnosing hypertension. Blood pressures taken at home were the most accurate and most preferred method for diagnosing hypertension. She is working with Kaiser Permanente Washington on their efforts to integrate home blood pressure monitoring into clinical care.
Dr. Green is also leading a National Cancer Institute study that is evaluating the effectiveness of home-based human papilloma virus (HPV) kits to increase completion of cervical cancer screening.
Dr. Green’s previous research has shown that:
She is a core member of the Alliance for Reducing Cancer, Northwest, a collaborative team of cancer prevention and control experts and community stakeholders whose mission is to evaluate and respond to gaps in the Guide to Community Preventive Services (the Community Guide). She serves on the steering committee of the National Colorectal Cancer Round Table (an elected position) and is on the U.S. Validated Blood Pressure Device Review Committee.
Dr. Green was honored by Kaiser Permanente Washington in 1999 for her contributions to clinical quality improvement and was a finalist for the organization's 2004 Lifetime Achievement Award. She was an associate editor for the American Journal of Preventive Medicine from 2009 to 2014, and she is an editorial board member of the Journal of the American Board of Family Practice. She is a fellow of the American Heart Association, an honor given for contributions to the field.
Dr. Green is a clinical professor at the University of Washington School of Medicine, Department of Family Medicine, and a professor at the Kaiser Permanente Bernard J. Tyson School of Medicine, Department of Health Systems Science.
Baldwin LM, Coronado GD, West II, Schwartz MR, Meenan RT, Vollmer WM, Petrik AF, Shapiro JA, Kulkarni-Sharma YR, Green BB. Health plan-based mailed fecal testing for colorectal cancer screening among dual-eligible Medicaid/Medicare enrollees: Outcomes of 2 program models. Cancer. 2022 Jan 15;128(2):410-418. doi: 10.1002/cncr.33909. Epub 2021 Sep 29. PubMed
Tuzzio L, Meyers CM, Dember LM, Grudzen CR, Melnick ER, Staman KL, Huang SS, Richards J, DeBar L, Vazquez MA, Green BB, Coronado GD, Jarvik JG, Braciszewski J, Ho M, Wells BL, James K, Toto R, D'Onofrio G, Volandes A, Kuklinski MR, Catalano RF, Sterling SA, Morse EF, Curtis L, Larson EB. Accounting for quality improvement during the conduct of embedded pragmatic clinical trials within healthcare systems: NIH collaboratory case studies. Healthc (Amst). 2021 Jun;8 Suppl 1:100432. doi: 10.1016/j.hjdsi.2020.100432. Epub 2021 Jun 23. PubMed
Green BB, Anderson ML, Cook AJ, Chubak J, Fuller S, Meenan RT, Vernon SW. A centralized mailed program with stepped support increases time in compliance with colorectal cancer screening over 9 years: a randomized trial a randomized controlled trial. J Gen Intern Med. 2021 May 28:1-8. doi: 10.1007/s11606-021-06922-2. Epub ahead of print. PubMed
Bress AP, Cohen JB, Anstey DE, Conroy MB, Ferdinand KC, Fontil V, Margolis KL, Muntner P, Millar MM, Okuyemi KS, Rakotz MK, Reynolds K, Safford MM, Shimbo D, Stuligross J, Green BB, Mohanty AF. Inequities in hypertension control in the United States exposed and exacerbated by COVID-19 and the role of home blood pressure and virtual health care during and after the COVID-19 pandemic. J Am Heart Assoc. 2021 Jun;10(11):e020997. doi: 10.1161/JAHA.121.020997. Epub 2021 May 19. PubMed
Huguet N, Larson A, Angier H, Marino M, Green BB, Moreno L, DeVoe JE. Rates of undiagnosed hypertension and diagnosed hypertension without anti-hypertensive medication following the Affordable Care Act. Am J Hypertens. 2021 Apr 30:hpab069. doi: 10.1093/ajh/hpab069. [Epub ahead of print]. PubMed
New study builds on findings that home tests improve screening rates.
Bev Green, doctor and scientist, has tips for monitoring your blood pressure without leaving your house.
Research finds that mailing HPV test kits directly to patients increases cervical cancer screening rates.
AARP, June 3, 2024
How KPWHRI is contributing to better cancer screening and better outcomes for patients.